This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Brain Tumor Treatment Market

Rising Prevalence of Cancer & Early Screening of Symptoms to Amplify the Brain Tumor Treatment Market

Brain Tumor Treatment Market by Product, End-user & Region - Forecast 2022 - 2032

Brain Tumor Treatment Market Snapshot (2022-2032)

[302 Pages Report] The global brain tumor treatment market garnered a market value of US$ 2,946.17 Million in 2022 and is expected to accumulate a market value of US$ 5,904.82 Million by registering a CAGR of 7.2% in the forecast period 2022-2032. The rising prevalence of such cancer and the growing geriatric population are key drivers expected to nurture the growth of the brain tumor diagnosis market worldwide. The market for Brain Tumor Treatment registered a CAGR of 6.8% in the historical period 2022-2032

Data Points

Key Statistics

Brain Tumor Treatment Market Value 2022

US$ 2,946.17 Million

Brain Tumor Treatment Market Projected Value (2032)

US$ 5,904.82 Million

Brain Tumor Treatment Market CAGR (2022-2032)

7.2%

A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be benign or malignant. Brain tumor arises from brain tissue and rarely spreads. The tumor eventually compresses and damages other structures in the brain. According to American Brain Tumor Association (ABTA), there are two types of brain tumors - primary and secondary. Primary tumors arise from brain tissue and secondary tumors arise from other parts of the body and spread to the brain.

Gliomas are the most common type of primary tumor which arises from the brain’s glial tissue. Glioblastoma multifome is a fast-growing and of a higher grade when compared to other tumors. Advanced medications are available to treat brain tumors. Increasing pharmaceutical R&D spending is expected to provide lucrative growth for the global brain tumor treatment market over the forecasted period.

Based on region, North America is estimated to capture the highest share owing to the advanced healthcare facilities and hefty investment in the research program to find an effective treatment for brain tumors.

Customize this Report

Let us know your requirement to get
100% FREE customization

Brain Tumor Treatment Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)

The global demand for Brain Tumor Treatment is projected to increase at a CAGR of 7.2% during the forecast period between 2022 and 2032, reaching a total of US$ 5,904.82 Million in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.8%.

Over the years, accelerating research activities in the oncology sector and increasing adoption of advanced technologies for cancer treatment have augmented the demand for brain tumor therapeutics across the globe.

According to the Central Brain Tumor Registry of the United States (CBTRUS) statistical report of 2016, an estimated 79,270 new cases of primary malignant, non-malignant, and other CNS cancers were diagnosed in the U.S. in 2020 (26,070 primary malignant and 53,200 non-malignant). Thereby, the increasing prevalence of brain cancer cases across the globe is expected to propel the demand for brain tumor diagnosis/treatment throughout the forecast period.

Which Drivers underpin Brain Tumor Treatment Industry Expansion?

Growing on Chemotherapies and Increasing Awareness to Act as Principal Growth Drivers

An increase in the prevalence rate of brain tumors has fuelled the demand for effective treatment. For instance, as per the American Society of Clinical Oncology (ASCO), the brain tumor incidence rate growing at 2.6% compared to the last year. An estimated 22,850 cases are diagnosed with primary cancerous tumors of the brain in the U.S. Furthermore, the increasing geriatric population is also driving the brain tumor market.

As such, global companies are spending a significant portion of their revenue on R&D to develop novel medications. Numerous products related to novel drug delivery technologies are lined up for FDA approval. Increasing demand for advanced medication to treat brain tumors is expected to fuel the overall growth of the market. Increasing consumer awareness regarding the latest technological advancements in therapies, and medications are responsible for the growth of the global brain tumor treatment market.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors are limiting the Growth of the Brain Tumor Treatment Market?

High Cost of Treatment May Hamper the Market Expansion of Brain Tumor Treatment Market

Successfully treating brain tumors can be challenging. The body’s blood-brain barrier normally protects the brain and spinal cord from harmful chemicals. However, this barrier also keeps out many types of chemotherapy. Surgery can be difficult if the tumor is near a delicate part of the brain or spinal cord. Even when the surgeon can completely remove the original tumor, parts of the tumor may remain that are too small to be seen or removed during surgery. Radiation therapy can also damage healthy tissue.

However, research in the past 20 years has helped to significantly lengthen the lives and improved the quality of life for many people with brain tumors. These advancements include more refined surgeries, a better understanding of which types of tumors respond to chemotherapy and other drugs, and more targeted delivery of radiation therapy. Besides, the higher initial cost of treatment and clinical trials are may act as major road blocks over the coming years.

Region-wise Insights

Will North America Hold a Significant Position in the Global Brain Tumor Treatment Market?

Advanced Healthcare Infrastructure & Presence of Innovative Research Centres to Nurture the Demand for Brain Tumor Treatment

North America region is expected to dominate the global brain tumor treatment market throughout the forecast period, owing to increasing incidences of glioblastoma coupled with technological advancements. North America is expected to account for a 34% share in the global brain tumor treatment market in 2022. Advanced healthcare infrastructure, greater per capita healthcare spending, and comparatively higher awareness regarding advanced technologies are certain to impact rendering factors.

Besides, the presence of advanced healthcare facilities and innovative research centers is another reason for fuelling the demand for brain tumor treatment & therapeutics. For instance, the UCSF Brain Tumor Center is one of the largest and most comprehensive programs in the region for the treatment of brain and spinal tumors. This center includes advanced intra-operative imaging and brain mapping techniques to protect areas of the brain used for language, motor skills, and sensory function during surgery, as well as radiosurgery with Gamma Knife and CyberKnife and access to clinical trials of promising new therapies.

How Will Growth of the European Brain Tumor Treatment Market unfold?

Encouraging Healthcare Programs & Increasing Clinical Trials for Novel Drug Development to Spur Demand for Brain Tumor Treatment

Europe is expected to contribute significantly to this space over the forecast period, which can be attributed to the increasing prevalence of malignant cancers in countries like the U.K. For instance, as per statistics provided by the Office for National Statistics, UK, in 2021, around 11,000 new cases were registered in the region.

Europe is the second largest in terms of market revenue and is estimated to witness significant gains throughout the forecast period. As per Future Market Insights, Europe is slated to account for 21% share of the global brain tumor treatment market. This market growth is attributed to the increasing emphasis on cancer research and the rising prevalence of cancer cases in the region.

EANO is Europe’s multidisciplinary Neuro-Oncology organization representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumors of the central nervous system (CNS). EANO is dedicated to promoting advances in Neuro-Oncology through innovative research and concerted education and training. Moreover, encouraging healthcare programs and the adoption of state-of-the-art technologies for the identification and treatment of malignant cancers in hospitals and healthcare facilities is likely to propel the brain tumor treatment market in the region.

How will Asia Pacific Bolster the Demand for Brain Tumor Treatment?

Increasing Adoption of Cutting-edge Technology in Several Countries to Escalate the Market Growth of Brain Tumor Treatment

The Asia Pacific represents a significant share of the brain tumor treatment market and is projected to experience robust growth throughout the forecast period, states Future Market Insights report. A significant increase in the incidence rate of brain tumors along with the shifting of locus of economic activity and dynamism to this region is expected to boost the demand for drugs responsible for brain tumor treatment.

The development of novel drugs and increasing clinical trials have boosted the market growth of the brain tumor treatment market in the APAC region. The encouraging healthcare policies and smooth drug approval program by FDA is another aspect driving the market for brain tumor treatment.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

The Start-Up Ecosystem: How key Players are Opening Frontiers for Future Growth?

  • Founded in 2004, ViewRay is a developer of MRI-guided radiation therapy for the treatment of cancer. The company's MRI-enabled radiotherapy can be used to provide continuous soft-tissue imaging during treatment. The technology has potential applications in treating Lung, Breast, prostate, and Head/Neck cancers. The startup is based out of Oakwood (United States) and has raised the overall funding of US$ 177 Million to date.
  • Launched in 2009, RefleXion Medical is a Hayward (U.S) based firm that developing a biology-guided radiotherapy (BgRT) system for targeted, personalized cancer treatment. Its patented technology leverages Positron Emission Tomography (PET) which allows tumors to continuously signal their location during treatment and guides personalized radiation therapy. The technology has applications in the treatment of Lung, prostate, and Breast cancers.

Competitive Landscape: What are the Leading Players in the Brain Tumor Treatment Market Up to?

  • In June 2022, Bristol Myers Squibb and Turning Point Therapeutics, Inc. announced a definitive merger agreement under which Bristol Myers Squibb will acquire Turning Point Therapeutics for $76.00 per share. The transaction was unanimously approved by both the Bristol Myers Squibb and Turning Point Therapeutics Board of Directors and is anticipated to close during the third quarter of 2022.
  • In August 2022, American drug maker Pfizer announced a deal to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.
  • In June 2022, Novartis AG's medicine capmatinib helped reduce brain tumors in patients with a type of lung cancer in a mid-stage study. New data has shown that the drug benefited a subset of patients who had brain metastases in which tumors develop away from the initial site of cancer.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7.2% from 2022-2032

Market Value in 2022

US$ 2,946.17 Million

Market Value in 2032

US$ 5,904.82 Million

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Product
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Genetech U.S.A
  • Bristol Myers Squibb
  • Hoffmann- La Roche
  • AstraZeneca Plc.
  • Pfizer Inc.
  • Novartis AG
  • Antisense Pharma
  • Merck & Co
  • MacLeod’s Pharmaceutical Limited
  • Mankind Pharma
  • Siemens Healthineers AG
  • Dr. Reddy’s Laboratories Ltd.

Key Segments Covered in the Brain Tumor Treatment Industry Analysis

Brain Tumor Treatment Market by Product:

  • Brain Tumor Treatment via Temozolomide
  • Brain Tumor Treatment via Carmustine
  • Brain Tumor Treatment via Cisplatin
  • Brain Tumor Treatment via Bevacizumab
  • Brain Tumor Treatment via Geftinib
  • Brain Tumor Treatment via Erlotinib

Brain Tumor Treatment Market by End User:

  • Brain Tumor Treatment in Hospital Pharmacies
  • Brain Tumor Treatment in Ambulatory Surgical Centers
  • Brain Tumor Treatment in Individual Pharmacies

Brain Tumor Treatment Market by Region:

  • North America Brain Tumor Treatment Market
  • Latin America Brain Tumor Treatment Market
  • Europe Brain Tumor Treatment Market
  • Asia Pacific Brain Tumor Treatment Market
  • Middle East & Africa Brain Tumor Treatment Market

Frequently Asked Questions

As of 2022, the Brain Tumor Treatment market is slated to reach a valuation of US$ 2,946.17 Million

From 2022-2032, sales of Brain Tumor Treatment are expected to grow at a 7.2% CAGR

By 2032, Future Market Insights expects the brain tumor treatment market to reach US$ 5,904.82 Million

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Brain Tumor Treatment Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032

        5.3.1. Temozolomide

        5.3.2. Carmustine

        5.3.3. Cisplatin

        5.3.4. Bevacizumab

        5.3.5. Geftinib

        5.3.6. Erlotinib

    5.4. Y-o-Y Growth Trend Analysis By Product, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Product, 2022-2032

6. Global Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Hospital Pharmacies

        6.3.2. Ambulatory Surgical Centers

        6.3.3. Individual Pharmacies

    6.4. Y-o-Y Growth Trend Analysis By End User, 2016-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. US

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Product

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Product

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Brain Tumor Treatment Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Product

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Brain Tumor Treatment Market Analysis

    13.1. US

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Product

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Product

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Product

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Product

            13.4.2.2. By End User

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Product

            13.5.2.2. By End User

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Product

            13.6.2.2. By End User

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Product

            13.7.2.2. By End User

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Product

            13.8.2.2. By End User

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Product

            13.9.2.2. By End User

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Product

            13.10.2.2. By End User

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Product

            13.11.2.2. By End User

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Product

            13.12.2.2. By End User

    13.13. GCC Countries

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Product

            13.13.2.2. By End User

    13.14. South Africa

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Product

            13.14.2.2. By End User

    13.15. Israel

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Product

            13.15.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Product

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Genetech

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Bristol Myers Squibb

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Hoffmann- La Roche

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. AstraZeneca

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Pfizer

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Novartis AG

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Antisense Pharma

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Merck & Co

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Macleods Pharmaceutical Limited

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Mankind Pharma

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

        15.1.11. Siemens Healthineers AG

            15.1.11.1. Overview

            15.1.11.2. Product Portfolio

            15.1.11.3. Profitability by Market Segments

            15.1.11.4. Sales Footprint

            15.1.11.5. Strategy Overview

                15.1.11.5.1. Marketing Strategy

        15.1.12. Amgen Inc.

            15.1.12.1. Overview

            15.1.12.2. Product Portfolio

            15.1.12.3. Profitability by Market Segments

            15.1.12.4. Sales Footprint

            15.1.12.5. Strategy Overview

                15.1.12.5.1. Marketing Strategy

        15.1.13. Dr. Reddy’s Laboratories Ltd

            15.1.13.1. Overview

            15.1.13.2. Product Portfolio

            15.1.13.3. Profitability by Market Segments

            15.1.13.4. Sales Footprint

            15.1.13.5. Strategy Overview

                15.1.13.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Brain Tumor Treatment Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global Brain Tumor Treatment Market Value (US$ Mn) Forecast by Product, 2016-2032

Table 3: Global Brain Tumor Treatment Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 4: North America Brain Tumor Treatment Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 5: North America Brain Tumor Treatment Market Value (US$ Mn) Forecast by Product, 2016-2032

Table 6: North America Brain Tumor Treatment Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 7: Latin America Brain Tumor Treatment Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 8: Latin America Brain Tumor Treatment Market Value (US$ Mn) Forecast by Product, 2016-2032

Table 9: Latin America Brain Tumor Treatment Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 10: Europe Brain Tumor Treatment Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 11: Europe Brain Tumor Treatment Market Value (US$ Mn) Forecast by Product, 2016-2032

Table 12: Europe Brain Tumor Treatment Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 13: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) Forecast by Product, 2016-2032

Table 15: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 16: MEA Brain Tumor Treatment Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 17: MEA Brain Tumor Treatment Market Value (US$ Mn) Forecast by Product, 2016-2032

Table 18: MEA Brain Tumor Treatment Market Value (US$ Mn) Forecast by End User, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Brain Tumor Treatment Market Value (US$ Mn) by Product, 2022-2032

Figure 2: Global Brain Tumor Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Brain Tumor Treatment Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Brain Tumor Treatment Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 5: Global Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Brain Tumor Treatment Market Value (US$ Mn) Analysis by Product, 2016-2032

Figure 8: Global Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 9: Global Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 10: Global Brain Tumor Treatment Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 11: Global Brain Tumor Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Brain Tumor Treatment Market Attractiveness by Product, 2022-2032

Figure 14: Global Brain Tumor Treatment Market Attractiveness by End User, 2022-2032

Figure 15: Global Brain Tumor Treatment Market Attractiveness by Region, 2022-2032

Figure 16: North America Brain Tumor Treatment Market Value (US$ Mn) by Product, 2022-2032

Figure 17: North America Brain Tumor Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Brain Tumor Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Brain Tumor Treatment Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 20: North America Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Brain Tumor Treatment Market Value (US$ Mn) Analysis by Product, 2016-2032

Figure 23: North America Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 24: North America Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 25: North America Brain Tumor Treatment Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 26: North America Brain Tumor Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Brain Tumor Treatment Market Attractiveness by Product, 2022-2032

Figure 29: North America Brain Tumor Treatment Market Attractiveness by End User, 2022-2032

Figure 30: North America Brain Tumor Treatment Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Brain Tumor Treatment Market Value (US$ Mn) by Product, 2022-2032

Figure 32: Latin America Brain Tumor Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Brain Tumor Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Brain Tumor Treatment Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 35: Latin America Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Brain Tumor Treatment Market Value (US$ Mn) Analysis by Product, 2016-2032

Figure 38: Latin America Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 39: Latin America Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 40: Latin America Brain Tumor Treatment Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 41: Latin America Brain Tumor Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Brain Tumor Treatment Market Attractiveness by Product, 2022-2032

Figure 44: Latin America Brain Tumor Treatment Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Brain Tumor Treatment Market Attractiveness by Country, 2022-2032

Figure 46: Europe Brain Tumor Treatment Market Value (US$ Mn) by Product, 2022-2032

Figure 47: Europe Brain Tumor Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Brain Tumor Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Brain Tumor Treatment Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 50: Europe Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Brain Tumor Treatment Market Value (US$ Mn) Analysis by Product, 2016-2032

Figure 53: Europe Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 54: Europe Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 55: Europe Brain Tumor Treatment Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 56: Europe Brain Tumor Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Brain Tumor Treatment Market Attractiveness by Product, 2022-2032

Figure 59: Europe Brain Tumor Treatment Market Attractiveness by End User, 2022-2032

Figure 60: Europe Brain Tumor Treatment Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) by Product, 2022-2032

Figure 62: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 65: Asia Pacific Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) Analysis by Product, 2016-2032

Figure 68: Asia Pacific Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 69: Asia Pacific Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 70: Asia Pacific Brain Tumor Treatment Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 71: Asia Pacific Brain Tumor Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Brain Tumor Treatment Market Attractiveness by Product, 2022-2032

Figure 74: Asia Pacific Brain Tumor Treatment Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Brain Tumor Treatment Market Attractiveness by Country, 2022-2032

Figure 76: MEA Brain Tumor Treatment Market Value (US$ Mn) by Product, 2022-2032

Figure 77: MEA Brain Tumor Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Brain Tumor Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Brain Tumor Treatment Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 80: MEA Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Brain Tumor Treatment Market Value (US$ Mn) Analysis by Product, 2016-2032

Figure 83: MEA Brain Tumor Treatment Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 84: MEA Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 85: MEA Brain Tumor Treatment Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 86: MEA Brain Tumor Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Brain Tumor Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Brain Tumor Treatment Market Attractiveness by Product, 2022-2032

Figure 89: MEA Brain Tumor Treatment Market Attractiveness by End User, 2022-2032

Figure 90: MEA Brain Tumor Treatment Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Brain Cancer Diagnostics Market

Published : December 2016

Healthcare

Brain Imaging And Neuroimaging Market

Published : September 2016

Healthcare

Brain Metastasis Therapeutics Market

Published : April 2016

Healthcare

Brain Monitoring Systems Market

Published : March 2022

Google translate

Brain Tumor Treatment Market